Phase II Study of Bevacizumab and Erlotinib in Elderly Patients with Advanced Non-Small Cell Lung Cancer

Pts must be 70 yrs. old or greater and newly diagnosed.  The treatment is every 3 weeks Bevacizumab(Avastin) IV and daily oral Tarceva.